Pen shown delivers doses of 2 mg.
Ozempic® is the only GLP-1 approved for all of these uses for adults with type 2 diabetes:
Ozempic® lowers the risk of worsening kidney disease, kidney failure (end-stage kidney disease), and death due to cardiovascular disease in adults who also have chronic kidney disease.
Maria has type 2 diabetes and takes Ozempic®.
Paid spokesperson of Novo Nordisk.
Franklin has type 2 diabetes and takes Ozempic®.
Paid spokesperson of Novo Nordisk.
The American Diabetes Association recommends that a reasonable goal for most adults with type 2 diabetes is an A1C less than 7%. Your health care professional will tell you what goal is right for you.
A majority of adults taking Ozempic® reached an A1C under 7% and maintained it.b
aIn 2 different studies, adults with type 2 diabetes lowered A1C, on average, by:
from a starting average A1C of 8.0% and 8.9%, respectively.
bIn the same 2 studies, the majority of people reached an A1C under 7%:
People with type 2 diabetes and known heart disease are at a greater risk of major cardiovascular events such as stroke, heart attack, or death. Ozempic® is proven to lower those risks.
Ozempic® lowers the risk of major cardiovascular events such as stroke, heart attack, or death in adults who also have heart disease.
Tom has type 2 diabetes and takes Ozempic®.
Tom also has known heart disease. Paid spokesperson of Novo Nordisk.
Talk to your health care professional to see if once‑weekly Ozempic® is right for you.
Receive reminders to take your medicine along with other helpful information and support. Text BEGIN to 21848 to get started.c
cMessage and data rates may apply. Check with your mobile service provider. Message frequency will be based on your selections. Text HELP to 21848 for help. Text STOP to 21848 to quit. See Terms and Conditions of Use.
Actor portrayals.
In adults with type 2 diabetes and chronic kidney disease, there is an increased risk of the disease worsening, or of experiencing cardiovascular death. Ozempic® is proven to significantly lower those risks, including the risk for kidney failure and death due to cardiovascular disease.
Ozempic® is the first and only medicine in its class (GLP-1) proven to help lower the risk of worsening kidney disease, kidney failure (end-stage kidney disease), and death due to cardiovascular disease in adults who also have chronic kidney disease.
Maria has type 2 diabetes and takes Ozempic®.
Paid spokesperson of Novo Nordisk.
— Maria's Ozempic® story
Ozempic® is not a weight-loss drug.
Just one dose of Ozempic® works around the clock for a whole week. Take it once a week on the same day every week, exactly as prescribed by your health care professional. You can take it with or without food.